Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
12/09/2025
Sino-US declaration: Unordered fluctuations in exchange rates may have adverse effects on economic and financial stability.
Latest
2 m ago
Hong Kong stocks surged | Meitu Company (01357.HK) rose more than 5%, joining hands with Tongyi Wanxiang to continue promoting the industrialization of AIGC technology in multiple fields.
3 m ago
In the first half of the year, market regulation departments have achieved significant results in cracking down on infringement and counterfeiting.
4 m ago
Gao Jianhui, former director-level inspector of the Henan Provincial Committee inspection team, is under disciplinary review and investigation by the supervisory authorities.
5 m ago
The three major indices collectively turned red.
6 m ago
Hong Kong stocks news | Pharmaron Health-B (02617.HK) rises by over 18% again, with a total market value exceeding HK$50 billion. The phase II trial of Tenofovir Alafenamide for breast cancer was approved.
See all latest